Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant ...

Barclays analyst Vlad Sergievskii raised the firm’s price target on Schindler (SHLAF) to CHF 270 from CHF 260 and keeps an Overweight rating on ...

The dollar edged up against a basket of currencies but could fall slightly if U.S. inflation data due later come in lower than expected.

Explore why the USD/CHF pair may continue to rise, and what to expect in the coming months amid the Fed and SNB divergence ...

LEM HOLDING SA / Key word (s): 9 Month figures LEM faced headwinds in 9 months 2024/25 – 'Fit for Growth' program to deliver improvement in EBIT starting next year 07-Feb-2025 / 07:00 CET/CEST Release ...

Vontobel Holding on Friday reported 2.6 billion Swiss francs ($2.87 billion) in net new money for full-year 2024, falling ...

The coin will be launched exclusively at the 2025 World Money Fair. Swissmint to be guest of honour at World Money Fair On 1 July 2025, the 100th anniversary of the CHF 100 gold Vreneli will be marked ...

ZURICH, Jan 29 (Reuters) - Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

The Japanese yen rose 0.87% to 154.63 against the dollar after tightening up to 153.71, its strongest level since mid-December. The Swiss franc rose 0.50% against the greenback to $0.90155. The ...

The Japanese yen is gaining 0.8%, pushing the USD/JPY cross back below the 155 mark, while the Swiss franc is 0.5% stronger with USD/CHF at 0.9018. The U.S. dollar can often be an FX haven too ...

In 2024, the projected deficit was 2.6 billion Swiss Francs, a government website showed ... But one shouldn't claim 100% security," she said. Dealscategory Portuguese banking fund seeks best ...